BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04538378-completion@plaintrial.com
DTSTAMP:20260927T222002Z
DTSTART;VALUE=DATE:20240227
SUMMARY:Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adeno
 carcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuro
 endocrine Tumors — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04538378
URL:https://plaintrial.com/trial/NCT04538378
END:VEVENT
END:VCALENDAR